The report "Venous Thromboembolism Devices Market by Type of Device (Compression Stockings, Gradual or medical compression stockings, Anti-embolism stockings, Nonmedical support hosiery, Intermitted pneumatic compression devices, Inferior vena cava filters, Retrievable IVC filters, Permanent IVC Filters), by Disease Type ( Deep vein thrombosis, Pulmonary embolism) by End-User (Hospitals, Diagnostic Centers, Ambulatory surgical Centres) - Global Forecasts to 2030"
The global venous thromboembolism devices market is projected to reach USD 956 million in 2023, registering a Compound Annual Growth Rate (CAGR) of 8.6% during the forecast period 2024-2030. The growth of the market is majorly driven by the geriatric population is expected to increase the patient population globally.
A vein-based blood clot is referred to medically as a venous thromboembolism (abbreviated VTE). This illness, which strikes between 300,000 and 600,000 Americans annually, is the third most frequent type of vascular disease after heart attacks and strokes. Venous thromboembolism is most frequently caused by being immobilized, undergoing surgery, being hospitalized, or having cancer. One of the other risk factors is immobility.
Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=17166
Scope of The Report:
- The venous thromboembolism devices market research report includes historical data, trending features, and market growth estimates for the future.
- The qualitative and quantitative analysis of the market along with CAGR calculation for the forecast period.
- The market report helps to provide the best results for business enhancement and business growth.
- The report gives a comprehensive overview of both primary and secondary data.
- The venous thromboembolism devices market key players covered here to help them strengthen their place in the market.
Regional Overview:
The report also examines the current concerns and their Future Effects on the venous thromboembolism devices market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the venous thromboembolism devices market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.
- North America (U.S., Canada)
- Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
- Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
- Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)
A Few Points from the Table of Contents –
1. Executive Summary
2. Global Venous Thromboembolism Devices Market Introduction
3. Global Venous Thromboembolism Devices Market Dynamics
4. Global Venous Thromboembolism Devices Market Analysis, 2019 - 2023 and Forecast 2024 – 2030
……………….
9. Global Venous Thromboembolism Devices Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10. North America Venous Thromboembolism Devices Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11. Europe Venous Thromboembolism Devices Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12. Asia Pacific (APAC) Venous Thromboembolism Devices Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13. Middle East and Africa (MEA) Venous Thromboembolism Devices Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14. Latin America Venous Thromboembolism Devices Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
15. Competition Landscape
16. Research Methodology
17. Appendix and Abbreviations
Competitive Dashboard:
The prominent key players operating in the global venous thromboembolism devices market are Aspen Holdings (U.S.)., Changzhaou Qianhong Bio-pharma Co., ltd. (China), Fresenius Kabi AG (Germany), Hebei Changshan Biochemical Pharmaceutical Co. Ltd. (China), Hikma Pharmaceuticals PLC (U.K.), Novartis AG (Switzerland), Janssen Global Services, LLC (U.S.), Pfizer Inc (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Mylan N.V. (U.S.)
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to delivering more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747
